Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Share
Tweet
Email
Embed
HintAnswer
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
MOA: Anti-organ rejection drug
Second line agent for RRMS that produces reduction in progression of disabilty
Bupropion class
Second line agent MOA: monoclonal Ab
Second line agent: RRMS, SPMS, Progressive Relapsing MS
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Use: Depression. Also helps with fatigue
IFN beta 1-a (Rebif) class
Dalfampridine class
Mycophenolate class
Dose: IM weekly
Cyclophosphamide class
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
MOA: Immunomodulator/antineoplastic
Modafinil class
Glatiramer acetate class
Second line agent: RRMS. Reduced relapses & progression of disability
MOA: Antimetabolite and antifolate
Excreted by kidney: contraindicated in moderate to severe renal failure
Gabapentin class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
HintAnswer
Dose: 1 gram/day IV for 3-5 days
Methylphenidate class
Methotrexate class
Mitoxantrone class
Use: Fatigue
First line drugs for disease modification
Off line agent used in the treatment of acute attacks
MOA: Purine analog
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Use: For pts who do not respond to corticosteroids during acute attacks
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Methylprednisone class
MOA: alkylating agent
Dose: 1250 mg/day PO for 3-5 days
Tizanidine class
Carbamazepine class
Prednisone class
MOA: Immune modulator, exact mechanism not known.
Use: pain and paroxysmal disorders
Dose: Oral. In extreme cases intrathecal
Natalizumab class
Axathioprine class
HintAnswer
Dose: SC injection every other day
First line RRMS agent injected SC daily
IFN beta 1-a (Avonex) class
Duloxetine class
Dose: Oral daily (first PO MS drug)
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Baclofen class
Use: treatment of spasticity
Fingolimod class
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Venlafaxine class
Dose: IV infusion every 3 months
IFN beta 1-b (Betaseron) class
Use: Fatigue, cognitive impairment (long acting agent)
Use: Depression. Also helps with pain
Alemtizumab class
Second line agent given IV monthy
Dose: SC injection 2-3 times weekly
Plasmapheresis class
Tricyclic class
Rituximab class
Daclizumab class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras